company background image
CBD

Cannabis Poland WSE:CBD Stock Report

Last Price

zł0.24

Market Cap

zł6.4m

7D

1.7%

1Y

-88.8%

Updated

29 Sep, 2022

Data

Company Financials
CBD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

CBD Stock Overview

Cannabis Poland S.A. operates in cannabis industry.

Cannabis Poland S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cannabis Poland
Historical stock prices
Current Share Pricezł0.24
52 Week Highzł2.35
52 Week Lowzł0.18
Beta0.20
1 Month Change4.35%
3 Month Change-81.96%
1 Year Change-88.84%
3 Year Change-74.19%
5 Year Change-70.73%
Change since IPO-78.18%

Recent News & Updates

Shareholder Returns

CBDPL PharmaceuticalsPL Market
7D1.7%0.3%-4.3%
1Y-88.8%-0.4%-33.1%

Return vs Industry: CBD underperformed the Polish Pharmaceuticals industry which returned -0.4% over the past year.

Return vs Market: CBD underperformed the Polish Market which returned -33.1% over the past year.

Price Volatility

Is CBD's price volatile compared to industry and market?
CBD volatility
CBD Average Weekly Movement33.4%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.1%
10% most volatile stocks in PL Market11.7%
10% least volatile stocks in PL Market3.8%

Stable Share Price: CBD is more volatile than 90% of Polish stocks over the past 3 months, typically moving +/- 33% a week.

Volatility Over Time: CBD's weekly volatility has increased from 18% to 33% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a2n/ahttps://www.cannabispolandsa.com

Cannabis Poland S.A. operates in cannabis industry. The company was formerly known as Telehorse S.A. and changed its name to Cannabis Poland S.A. in May 2019. Cannabis Poland S.A. is based in Warsaw, Poland.

Cannabis Poland S.A. Fundamentals Summary

How do Cannabis Poland's earnings and revenue compare to its market cap?
CBD fundamental statistics
Market Capzł6.35m
Earnings (TTM)-zł767.78k
Revenue (TTM)zł362.94k

17.5x

P/S Ratio

-8.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CBD income statement (TTM)
Revenuezł362.94k
Cost of Revenuezł251.99k
Gross Profitzł110.95k
Other Expenseszł878.73k
Earnings-zł767.78k

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Nov 14, 2022

Earnings per share (EPS)-0.029
Gross Margin30.57%
Net Profit Margin-211.54%
Debt/Equity Ratio53.4%

How did CBD perform over the long term?

See historical performance and comparison